Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

NCT03728985 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT03728985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03728985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 17, 2019
Completion date
January 31, 2030
Enrollment
102 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

thoracoabdominal aortic aneurysm